TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cogstate Ltd ( (AU:CGS) ) just unveiled an announcement.
Cogstate Limited announced a change in the director’s interest as Richard Mohs acquired 13,000 ordinary shares through the OTC market, increasing his total holdings to 80,000 shares. This acquisition reflects a strategic move by the director, potentially signaling confidence in the company’s future prospects and stability, which could positively impact stakeholder perception and market positioning.
The most recent analyst rating on (AU:CGS) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Cogstate Ltd stock, see the AU:CGS Stock Forecast page.
More about Cogstate Ltd
Cogstate Limited operates in the healthcare industry, focusing on cognitive science and technology. The company provides digital cognitive assessment tools and services, primarily targeting clinical trials, academic research, and healthcare providers to enhance cognitive measurement and understanding.
Average Trading Volume: 86,746
Technical Sentiment Signal: Buy
Current Market Cap: A$295.1M
For an in-depth examination of CGS stock, go to TipRanks’ Overview page.